Literature DB >> 30725365

Stem Cells for the Oromaxillofacial Area: Could they be a promising source for regeneration in dentistry?

Ayşegül Mendi1, Hacer Ulutürk2, Mustafa Sancar Ataç2, Derviş Yılmaz2.   

Abstract

Oromaxillofacial tissues (OMT) are composed of tooth and bone, together with nerves and blood vessels. Such a composite material is a huge source for mesenchymal stem cells (MSCs) that can be obtained with ease from extracted teeth, teeth structures and socket blood, flapped gingiva tissue, and mandibular/maxillar bone marrow. They offer a biological answer for restoring damaged dental tissues such as the regeneration of alveolar bone, prevention of pulp tissue defects, and dental structures. Dental tissue-derived mesenchymal stem cells share properties with bone marrow-derived mesenchymal stem cells and there is a considerable potential for these cells to be used in different stem cell-based therapies, such as bone and nerve regeneration. Dental pulp tissue might be a very good source for neurological disorders whereas gingiva-derived mesenchymal stem cells could be a good immune modulatory/suppressive mediators. OMT-MSCs is also promising candidates for regeneration of orofacial tissues from the perspective of developmental fate. Here, we review the fundamental biology and potential for future regeneration strategies of MSCs in oromaxillofacial research.

Entities:  

Keywords:  Bone marrow mesenchymal stem cells; Dental pulp mesenchymal stem cells; Dental stem cells; Oromaxillofacial tissue; Tooth bank

Mesh:

Year:  2019        PMID: 30725365     DOI: 10.1007/5584_2018_327

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Characterization of Dental Pulp Stem Cell Responses to Functional Biomaterials Including Mineralized Trioxide Aggregates.

Authors:  Sejin Bae; Bueonguk Kang; Hyungbin Lee; Harrison Luu; Eric Mullins; Karl Kingsley
Journal:  J Funct Biomater       Date:  2021-02-24

Review 2.  Craniofacial Bone Tissue Engineering: Current Approaches and Potential Therapy.

Authors:  Arbi Aghali
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.